Drug-Resistant Epilepsy: Current Challenges and Solutions

Drug-resistant epilepsy remains a significant challenge in the field, with a substantial proportion of patients not achieving adequate seizure control with available antiepileptic medications. This session will explore the underlying factors contributing to drug resistance, including genetic, pharmacokinetic, and pharmacodynamic considerations. Understanding these mechanisms is crucial for developing new therapeutic strategies and optimizing treatment regimens for drug-resistant epilepsy.

Recent research is focused on identifying novel drug targets and developing innovative treatment approaches, such as personalized medicine and drug delivery systems. Advances in genetic and molecular research are providing insights into potential therapeutic targets and mechanisms of drug resistance. By addressing these challenges and exploring new solutions, the goal is to improve seizure control and quality of life for individuals with drug-resistant epilepsy.

    Related Conference of Drug-Resistant Epilepsy: Current Challenges and Solutions

    September 26-27, 2024

    7th Annual Congress on Emergency Medicine and Acute Care

    Amsterdam, Netherlands
    October 31-01, 2024

    8th International Conference on Internal Medicine

    Amsterdam, Netherlands
    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Aix-en-Provence, France

    Drug-Resistant Epilepsy: Current Challenges and Solutions Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in